Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Identification of the murine firefly luciferase-specific CD8 T-cell epitopes

Abstract

In vivo bioluminescence imaging of reporter enzymes has proven to be a uniquely powerful tool that allows the study of the biology of viral and nonviral gene transfer agents. Cost-effective, noninvasive, longitudinal gene transfer studies in individual animals yield important information, which can influence the design of subsequent preclinical studies. The broad and expanding use of luciferase transgenes, specifically firefly luciferase, has prompted the study of luciferase-specific T-cell activation following in vivo gene transfer. Herein, we report the mapping of the dominant T cell epitope in C57BL/6 mice (LMYRFEEEL) and the mapping of the dominant and minor T-cell epitopes in BALB/c mice (GFQSMYTFV and VPFHHGFGM, VALPHRTAC, respectively). These CD8 T-cell epitopes can be used to monitor cellular responses in vivo as well as be important tools in studies designed to suppress transgene-specific T cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 4
Figure 3

Similar content being viewed by others

References

  1. Ow DW, de Wet JR, Helinski DR, Howell SH, Wood KV, Deluca M . Transient and stable expression of the firefly luciferase gene in plant cells and transgenic plants. Science 1986; 234: 856–859.

    Article  CAS  PubMed  Google Scholar 

  2. Roda A, Pasini P, Mirasoli M, Michelini E, Guardigli M . Biotechnological applications of bioluminescence and chemiluminescence. Trends Biotechnol 2004; 22: 295–303.

    Article  CAS  PubMed  Google Scholar 

  3. Thomas CE, Ehrhardt A, Kay MA . Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346–358.

    Article  CAS  PubMed  Google Scholar 

  4. Oukka M, Cohen-Tannoudji M, Tanaka Y, Babinet C, Kosmatopoulos K . Medullary thymic epithelial cells induce tolerance to intracellular proteins. J Immunol 1996; 156: 968–975.

    CAS  PubMed  Google Scholar 

  5. Han WG, Unger WW, Wauben MH . Identification of the immunodominant CTL epitope of EGFP in C57BL/6 mice. Gene Therapy 2008; 15: 700–701.

    Article  CAS  PubMed  Google Scholar 

  6. Gambotto A, Dworacki G, Cicinnati V, Kenniston T, Steitz J, Tuting T et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Therapy 2000; 7: 2036–2040.

    Article  CAS  PubMed  Google Scholar 

  7. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ . Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993; 151: 3971–3980.

    CAS  PubMed  Google Scholar 

  8. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S . SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213–219.

    Article  CAS  PubMed  Google Scholar 

  9. Parker KC, Bednarek MA, Coligan JE . Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152: 163–175.

    CAS  PubMed  Google Scholar 

  10. Brusic V, Bajic VB, Petrovsky N . Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications. Methods 2004; 34: 436–443.

    Article  CAS  PubMed  Google Scholar 

  11. Pelte C, Cherepnev G, Wang Y, Schoenemann C, Volk HD, Kern F . Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J Immunol 2004; 172: 6783–6789.

    Article  CAS  PubMed  Google Scholar 

  12. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM . Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11–22.

    Article  CAS  PubMed  Google Scholar 

  13. Gao GP, Yang Y, Wilson JM . Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996; 70: 8934–8943.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Miller RA . Immunodeficiency of aging: restorative effects of phorbol ester combined with calcium ionophore. J Immunol 1986; 137: 805–808.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Deirdre McMenamin and Regina Munden for invaluable assistance with animal studies; Roberto Calcedo for expert assistance with FACS analysis; Arbans Sandhu and Julie Johnston (Penn Vector) for supplying the Ad.Hu5 vectors. This work was supported by grants from the Cystic Fibrosis Foundation (R881), P01-HL051746 and GSK. JMW is an inventor on patents licensed to various commercial entities.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Wilson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Limberis, M., Bell, C. & Wilson, J. Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 16, 441–447 (2009). https://doi.org/10.1038/gt.2008.177

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2008.177

Keywords

This article is cited by

Search

Quick links